In the November 2018 issue, Table 1 in the News Analysis “Wnt is back in drugmakers' sights, but is it druggable?” listed SM04554 as a Wnt pathway inhibitor; in fact, it is a Wnt pathway activator.
Rights and permissions
About this article
Cite this article
Correction. Nat Biotechnol 36, 1131 (2018). https://doi.org/10.1038/nbt1218-1131b
Published:
Issue Date:
DOI: https://doi.org/10.1038/nbt1218-1131b
